Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Pedro Russo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Contact Dermatitis|July 16, 2020
In vivo demonstration of immunologic cross-reactivity to octylisothiazolinone in patients primarily and strongly sensitized to methylisothiazolinoneJuan Pedro Russo, Olivier Aerts
Skinmed|March 19, 2011
Cutaneous and subcutaneous phaeohyphomycosisJuan Pedro Russo, Rocío Raffaeli, Stella Maris Ingratta, et al.
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|June 20, 2020
[Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina]Jorge Máspero, María Valeria Angles, Ledit Ardusso, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Contact Dermatitis|July 16, 2020
In vivo demonstration of immunologic cross-reactivity to octylisothiazolinone in patients primarily and strongly sensitized to methylisothiazolinoneJuan Pedro Russo, Olivier Aerts
Skinmed|March 19, 2011
Cutaneous and subcutaneous phaeohyphomycosisJuan Pedro Russo, Rocío Raffaeli, Stella Maris Ingratta, et al.
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|June 20, 2020
[Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina]Jorge Máspero, María Valeria Angles, Ledit Ardusso, et al.
Pageof 1